Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Protein Page:
FANCB (human)

Overview
FANCB DNA repair protein required for FANCD2 ubiquitination. Defects in FANCB are the cause of Fanconi anemia complementation group B (FANCB). It is a disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. Some severe FANCB cases manifest features of VACTERL syndrome with hydrocephalus. Note: This description may include information from UniProtKB.
Cellular Component: nucleoplasm
Molecular Function: protein binding
Biological Process: DNA repair
Reference #:  Q8NB91 (UniProtKB)
Alt. Names/Synonyms: FA2; FAAP90; FAAP95; FAB; FACB; FANCB; Fanconi anemia group B protein; Fanconi anemia, complementation group B; Fanconi anemia-associated polypeptide of 95 kDa; Protein FACB; type 2 Fanconi pancytopenia
Gene Symbols: FANCB
Molecular weight: 97,726 Da
Basal Isoelectric point: 7.79  Predict pI for various phosphorylation states
Select Structure to View Below

FANCB

Protein Structure Not Found.


STRING  |  Reactome  |  neXtProt  |  Protein Atlas  |  BioGPS  |  DISEASE  |  Scansite  |  Pfam  |  Phospho.ELM  |  Source  |  GeneCards  |  UniProtKB  |  Entrez-Gene  |  GenPept  |  Ensembl Gene


Modification Sites and Domains  

Modification Sites in Parent Protein, Orthologs, and Isoforms  
 

Show Multiple Sequence Alignment


 SS 

SS: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


 MS 

MS: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


       human

 
0 2 T555-p EAKRVTLtPDSKKEE
0 1 S795-p CEVSKGKssVVAAAL
0 1 S796-p EVSKGKssVVAAALs
0 1 S803-p sVVAAALsDRRENIH
0 1 T839-p GALYREItLKVAEVQ
  mouse

 
- gap
N638 CRIRRTDNRAMTFLG
- gap
L644 DNRAMTFLGRRAKIR
T679 GSSYAEMTLALAEIQ
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.